30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Global Blood Therapeutics Inc (GBT)

Track

Stock chart
Ticker: GBT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Farrow Jeffrey S
Chief Financial Officer
1 sale — total 2,137,988 USD
Sale 1 Sep 2022
Value US$4,574,154.64 | Price 394.12 | Shares 34,571
Sale 18 Aug 2022
Value US$2,899,150.48 | Price 271.16 | Shares 29,455
Planned sale 21 Jun 2022
Value US$34,337.14 | Price 27.25 | Shares 1,260
Planned sale 21 Jun 2022
Value US$51,982.70 | Price 27.24 | Shares 1,908
Planned sale 18 Jun 2021
Value US$58,792.86 | Price 36.54 | Shares 1,609
Buy 10 May 2021
Value US$18,980.00 | Price 37.96 | Shares 500
Planned sale 5 Oct 2020
Value US$271,920.00 | Price 60.00 | Shares 4,532
Sale 20 Aug 2020
Value US$140,294.00 | Price 63.77 | Shares 2,200
Planned sale 5 Aug 2020
Value US$66,595.76 | Price 70.10 | Shares 950
Planned sale 5 Aug 2020
Value US$104,255.02 | Price 69.32 | Shares 1,504
Planned sale 13 Jul 2020
Value US$1,140,600.00 | Price 75.00 | Shares 15,208
Planned sale 19 Jun 2020
Value US$56,749.97 | Price 64.42 | Shares 881
Planned sale 19 Jun 2020
Value US$105,913.31 | Price 63.69 | Shares 1,663
Planned sale 9 Jun 2020
Value US$1,018,936.00 | Price 67.00 | Shares 15,208
Sale 26 May 2020
Value US$189,270.00 | Price 70.10 | Shares 2,700
Sale 18 May 2020
Value US$1,742,051.10 | Price 74.67 | Shares 23,330
Sale 12 May 2020
Value US$102,521.65 | Price 79.17 | Shares 1,295
Sale 12 May 2020
Value US$2,728,931.77 | Price 78.65 | Shares 34,698
Sale 12 May 2020
Value US$1,012,138.02 | Price 77.71 | Shares 13,024
Sale 12 May 2020
Value US$45,770.52 | Price 76.28 | Shares 600
Sale 12 May 2020
Value US$101,833.47 | Price 75.43 | Shares 1,350
Sale 12 May 2020
Value US$194,865.17 | Price 74.01 | Shares 2,633
Sale 12 May 2020
Value US$234,512.36 | Price 78.38 | Shares 2,992
Sale 11 May 2020
Value US$29,355.75 | Price 77.05 | Shares 381
Planned sale 28 Apr 2020
Value US$3,200,160.00 | Price 80.00 | Shares 40,000
Planned sale 27 Apr 2020
Value US$122,319.81 | Price 80.63 | Shares 1,517
Planned sale 27 Apr 2020
Value US$105,493.96 | Price 81.15 | Shares 1,300
Planned sale 20 Apr 2020
Value US$306,000.00 | Price 75.00 | Shares 4,080
Buy 13 Mar 2020
Value US$523,700.00 | Price 52.37 | Shares 10,000
Planned sale 9 Mar 2020
Value US$56,186.20 | Price 59.90 | Shares 938
Planned sale 5 Mar 2020
Value US$74,311.40 | Price 65.30 | Shares 1,138
Planned sale 18 Feb 2020
Value US$128,939.65 | Price 70.92 | Shares 1,818
Planned sale 18 Feb 2020
Value US$153,720.77 | Price 70.22 | Shares 2,189
Planned sale 18 Feb 2020
Value US$91,529.23 | Price 69.71 | Shares 1,313
Planned sale 10 Feb 2020
Value US$44,050.00 | Price 70.48 | Shares 625
Planned sale 6 Feb 2020
Value US$285,038.80 | Price 72.40 | Shares 3,937
Planned sale 3 Feb 2020
Value US$82,155.48 | Price 62.81 | Shares 1,308
Planned sale 3 Feb 2020
Value US$107,705.00 | Price 65.00 | Shares 1,657
Planned sale 3 Feb 2020
Value US$137,428.28 | Price 62.81 | Shares 2,188
Planned sale 27 Jan 2020
Value US$55,568.15 | Price 71.15 | Shares 781
Planned sale 22 Jan 2020
Value US$85,011.00 | Price 82.45 | Shares 1,031
Planned sale 22 Jan 2020
Value US$2,631,599.67 | Price 81.85 | Shares 32,150
Planned sale 22 Jan 2020
Value US$552,435.83 | Price 81.01 | Shares 6,819
Planned sale 21 Jan 2020
Value US$43,702.66 | Price 83.56 | Shares 523
Planned sale 21 Jan 2020
Value US$841,561.81 | Price 82.78 | Shares 10,166
Planned sale 21 Jan 2020
Value US$2,402,836.64 | Price 81.98 | Shares 29,311
Planned sale 2 Jan 2020
Value US$104,352.24 | Price 79.78 | Shares 1,308
Sale 11 Dec 2019
Value US$164,698.49 | Price 77.25 | Shares 2,132
Sale 11 Dec 2019
Value US$2,132,529.03 | Price 76.52 | Shares 27,868
Planned sale 9 Dec 2019
Value US$73,554.50 | Price 78.50 | Shares 937
Planned sale 6 Dec 2019
Value US$282,973.40 | Price 76.15 | Shares 3,716
Planned sale 6 Dec 2019
Value US$1,799,327.14 | Price 77.72 | Shares 23,152
Planned sale 6 Dec 2019
Value US$522,121.68 | Price 76.78 | Shares 6,800
Planned sale 6 Dec 2019
Value US$479,511.60 | Price 75.73 | Shares 6,332
Planned sale 5 Dec 2019
Value US$508,873.05 | Price 75.39 | Shares 6,750
Planned sale 5 Dec 2019
Value US$636,478.20 | Price 74.66 | Shares 8,525
Planned sale 5 Dec 2019
Value US$73,783.68 | Price 74.08 | Shares 996
Planned sale 5 Dec 2019
Value US$937,474.84 | Price 75.35 | Shares 12,442
Planned sale 5 Dec 2019
Value US$842,261.90 | Price 74.62 | Shares 11,287
Planned sale 2 Dec 2019
Value US$229,185.16 | Price 66.74 | Shares 3,434
Planned sale 26 Nov 2019
Value US$778,933.67 | Price 67.19 | Shares 11,593
Planned sale 25 Nov 2019
Value US$39,360.00 | Price 60.00 | Shares 656
Planned sale 25 Nov 2019
Value US$275,640.00 | Price 60.00 | Shares 4,594
Planned sale 25 Nov 2019
Value US$17,880.00 | Price 60.00 | Shares 298
Planned sale 25 Nov 2019
Value US$26,820.00 | Price 60.00 | Shares 447
Planned sale 25 Nov 2019
Value US$210,900.00 | Price 60.00 | Shares 3,515
Planned sale 25 Nov 2019
Value US$66,480.00 | Price 60.00 | Shares 1,108
Planned sale 25 Nov 2019
Value US$18,720.00 | Price 60.00 | Shares 312
Planned sale 19 Nov 2019
Value US$360,910.00 | Price 55.00 | Shares 6,562
Planned sale 18 Nov 2019
Value US$33,213.28 | Price 50.63 | Shares 656
Planned sale 15 Nov 2019
Value US$497,446.76 | Price 50.00 | Shares 9,948
Planned sale 14 Nov 2019
Value US$16,454.51 | Price 50.01 | Shares 329
Planned sale 1 Nov 2019
Value US$106,334.36 | Price 48.33 | Shares 2,200
Planned sale 1 Nov 2019
Value US$54,857.29 | Price 48.68 | Shares 1,127
Sale 8 Oct 2019
Value US$241,332.85 | Price 45.05 | Shares 5,357
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-06 2022-09-01 S Sale
2.1
Farrow Jeffrey S

Chief Financial Officer

Officer
34,571 +7.3%
394.12
US$4,574,155 		34,571 +7.3% 394.12 US$4,574,155
2022-08-19 2022-08-18 S Sale
Habibizad Nazila

See Remarks

Officer
29,455 +48.9%
271.16
US$2,899,150 		29,455 +48.9% 271.16 US$2,899,150
2022-06-22 2022-06-21 PlS Planned sale
Pizzo Philip A.
Non-Executive Director
64,717 +10.9%
495.57
US$2,490,776 		64,717 +10.9% 495.57 US$2,490,776
2022-06-22 2022-06-21 PlS Planned sale
3.0
Svoronos Dawn
Non-Executive Director
1,908 -26.2%
27.24
US$51,983 		1,908 -26.2% 27.24 US$51,983
2021-06-21 2021-06-18 PlS Planned sale
3.0
Svoronos Dawn
Non-Executive Director
1,609 -30.4%
36.54
US$58,793 		1,609 -30.4% 36.54 US$58,793
2021-05-10 2021-05-10 B Purchase
1.5
Fink Eric

Chief Human Resources Officer

Officer
500 +10.7%
37.96
US$18,980 		500 +10.7% 37.96 US$18,980
2020-10-07 2020-10-05 PlS Planned sale
1.5
Fink Eric

Chief Human Resources Officer

Officer
4,532 -100.0%
60.00
US$271,920 		4,532 -100.0% 60.00 US$271,920
2020-08-24 2020-08-20 S Sale
3.2
CATHERS BRIAN EDWIN

Chief Scientific Officer

Officer
2,200 -29.6%
63.77
US$140,294 		2,200 -29.6% 63.77 US$140,294
2020-08-07 2020-08-05 PlS Planned sale
1.5
Fink Eric

Chief Human Resources Officer

Officer
950 -100.0%
70.10
US$66,596 		950 -100.0% 70.10 US$66,596
2020-08-07 2020-08-05 PlS Planned sale
1.5
Fink Eric

Chief Human Resources Officer

Officer
1,504 -61.3%
69.32
US$104,255 		1,504 -61.3% 69.32 US$104,255
2020-07-15 2020-07-13 PlS Planned sale
2.1
Farrow Jeffrey S

Chief Financial Officer

Officer
15,208 -83.3%
75.00
US$1,140,600 		15,208 -83.3% 75.00 US$1,140,600
2020-06-19 2020-06-19 PlS Planned sale
3.0
Svoronos Dawn
Non-Executive Director
881 -28.1%
64.42
US$56,750 		881 -28.1% 64.42 US$56,750
2020-06-19 2020-06-19 PlS Planned sale
3.0
Svoronos Dawn
Non-Executive Director
1,663 -34.6%
63.69
US$105,913 		1,663 -34.6% 63.69 US$105,913
2020-06-11 2020-06-09 PlS Planned sale
2.1
Farrow Jeffrey S

Chief Financial Officer

Officer
15,208 -45.4%
67.00
US$1,018,936 		15,208 -45.4% 67.00 US$1,018,936
2020-05-28 2020-05-26 S Sale
3.6
Calhoun Lesley Ann

See Remarks

Officer
2,700 -94.6%
70.10
US$189,270 		2,700 -94.6% 70.10 US$189,270
2020-05-20 2020-05-18 S Sale
3.6
Calhoun Lesley Ann

See Remarks

Officer
23,330 -99.3%
74.67
US$1,742,051 		23,330 -99.3% 74.67 US$1,742,051
2020-05-13 2020-05-12 S Sale
2.3
PERRY MARK L
Non-Executive Director
1,295 -4.7%
79.17
US$102,522 		1,295 -4.7% 79.17 US$102,522
2020-05-13 2020-05-12 S Sale
2.3
PERRY MARK L
Non-Executive Director
34,698 -55.6%
78.65
US$2,728,932 		34,698 -55.6% 78.65 US$2,728,932
2020-05-13 2020-05-12 S Sale
2.3
PERRY MARK L
Non-Executive Director
13,024 -17.3%
77.71
US$1,012,138 		13,024 -17.3% 77.71 US$1,012,138
2020-05-13 2020-05-12 S Sale
2.3
PERRY MARK L
Non-Executive Director
600 -0.8%
76.28
US$45,771 		600 -0.8% 76.28 US$45,771
2020-05-13 2020-05-12 S Sale
2.3
PERRY MARK L
Non-Executive Director
1,350 -1.7%
75.43
US$101,833 		1,350 -1.7% 75.43 US$101,833
2020-05-13 2020-05-12 S Sale
2.3
PERRY MARK L
Non-Executive Director
2,633 -3.3%
74.01
US$194,865 		2,633 -3.3% 74.01 US$194,865
2020-05-13 2020-05-12 S Sale
3.6
Calhoun Lesley Ann

See Remarks

Officer
2,992 -95.1%
78.38
US$234,512 		2,992 -95.1% 78.38 US$234,512
2020-05-13 2020-05-11 S Sale
3.6
Calhoun Lesley Ann

See Remarks

Officer
381 -10.8%
77.05
US$29,356 		381 -10.8% 77.05 US$29,356
2020-04-29 2020-04-28 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
40,000 -3.7%
80.00
US$3,200,160 		40,000 -3.7% 80.00 US$3,200,160
2020-04-29 2020-04-27 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
1,517 -0.1%
80.63
US$122,320 		1,517 -0.1% 80.63 US$122,320
2020-04-29 2020-04-27 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
1,300 -0.1%
81.15
US$105,494 		1,300 -0.1% 81.15 US$105,494
2020-04-22 2020-04-20 PlS Planned sale
SUVARI TRICIA BORGA

Chief Legal Officer

Officer
4,080 -35.4%
75.00
US$306,000 		4,080 -35.4% 75.00 US$306,000
2020-03-17 2020-03-13 B Purchase
3.2
Brown Willie L. Jr.
Non-Executive Director
10,000 +46.7%
52.37
US$523,700 		10,000 +46.7% 52.37 US$523,700
2020-03-09 2020-03-09 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer

Officer
938 -26.5%
59.90
US$56,186 		938 -26.5% 59.90 US$56,186
2020-03-09 2020-03-05 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer

Officer
1,138 -30.5%
65.30
US$74,311 		1,138 -30.5% 65.30 US$74,311
2020-02-20 2020-02-18 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
1,818 -0.2%
70.92
US$128,940 		1,818 -0.2% 70.92 US$128,940
2020-02-20 2020-02-18 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
2,189 -0.2%
70.22
US$153,721 		2,189 -0.2% 70.22 US$153,721
2020-02-20 2020-02-18 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer

Officer
1,313 -33.6%
69.71
US$91,529 		1,313 -33.6% 69.71 US$91,529
2020-02-10 2020-02-10 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer

Officer
625 -19.4%
70.48
US$44,050 		625 -19.4% 70.48 US$44,050
2020-02-10 2020-02-06 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer

Officer
3,937 -60.3%
72.40
US$285,039 		3,937 -60.3% 72.40 US$285,039
2020-02-04 2020-02-03 PlS Planned sale
SUVARI TRICIA BORGA

Chief Legal Officer
1,308 -10.2%
62.81
US$82,155 		1,308 -10.2% 62.81 US$82,155
2020-02-04 2020-02-03 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
1,657 -20.2%
65.00
US$107,705 		1,657 -20.2% 65.00 US$107,705
2020-02-04 2020-02-03 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
2,188 -25.1%
62.81
US$137,428 		2,188 -25.1% 62.81 US$137,428
2020-01-29 2020-01-27 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
781 -27.9%
71.15
US$55,568 		781 -27.9% 71.15 US$55,568
2020-01-23 2020-01-22 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
1,031 -0.1%
82.45
US$85,011 		1,031 -0.1% 82.45 US$85,011
2020-01-23 2020-01-22 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
32,150 -2.9%
81.85
US$2,631,600 		32,150 -2.9% 81.85 US$2,631,600
2020-01-23 2020-01-22 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
6,819 -0.6%
81.01
US$552,436 		6,819 -0.6% 81.01 US$552,436
2020-01-23 2020-01-21 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
523 -0.0%
83.56
US$43,703 		523 -0.0% 83.56 US$43,703
2020-01-23 2020-01-21 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
10,166 -0.9%
82.78
US$841,562 		10,166 -0.9% 82.78 US$841,562
2020-01-23 2020-01-21 PlS Planned sale
LOVE TED W

See Remarks

Executive Director
29,311 -2.6%
81.98
US$2,402,837 		29,311 -2.6% 81.98 US$2,402,837
2020-01-03 2020-01-02 PlS Planned sale
SUVARI TRICIA BORGA

Chief Legal Officer
1,308 -13.5%
79.78
US$104,352 		1,308 -13.5% 79.78 US$104,352
2019-12-13 2019-12-11 S Sale Pizzo Philip A. Non-Executive Director
2,132 -100.0%
77.25
US$164,698 		2,132 -100.0% 77.25 US$164,698
2019-12-13 2019-12-11 S Sale Pizzo Philip A. Non-Executive Director
27,868 -92.9%
76.52
US$2,132,529 		27,868 -92.9% 76.52 US$2,132,529
2019-12-11 2019-12-09 PlS Planned sale Lehrer-Graiwer Joshua

Chief Medical Officer

Officer
937 -100.0%
78.50
US$73,554 		937 -100.0% 78.50 US$73,554
2019-12-09 2019-12-06 PlS Planned sale LOVE TED W

See Remarks.

Executive Director
3,716 -0.3%
76.15
US$282,973 		3,716 -0.3% 76.15 US$282,973
2019-12-09 2019-12-06 PlS Planned sale LOVE TED W

See Remarks.

Executive Director
23,152 -2.1%
77.72
US$1,799,327 		23,152 -2.1% 77.72 US$1,799,327
2019-12-09 2019-12-06 PlS Planned sale LOVE TED W

See Remarks.

Executive Director
6,800 -0.6%
76.78
US$522,122 		6,800 -0.6% 76.78 US$522,122
2019-12-09 2019-12-06 PlS Planned sale LOVE TED W

See Remarks.

Executive Director
6,332 -0.6%
75.73
US$479,512 		6,332 -0.6% 75.73 US$479,512
2019-12-09 2019-12-05 PlS Planned sale LOVE TED W

See Remarks.

Executive Director
6,750 -0.6%
75.39
US$508,873 		6,750 -0.6% 75.39 US$508,873
2019-12-09 2019-12-05 PlS Planned sale LOVE TED W

See Remarks.

Executive Director
8,525 -0.7%
74.66
US$636,478 		8,525 -0.7% 74.66 US$636,478
2019-12-09 2019-12-05 PlS Planned sale LOVE TED W

See Remarks.

Executive Director
996 -0.1%
74.08
US$73,784 		996 -0.1% 74.08 US$73,784
2019-12-09 2019-12-05 PlS Planned sale LOVE TED W

See Remarks.

Executive Director
12,442 -1.1%
75.35
US$937,475 		12,442 -1.1% 75.35 US$937,475
2019-12-09 2019-12-05 PlS Planned sale LOVE TED W

See Remarks.

Executive Director
11,287 -1.0%
74.62
US$842,262 		11,287 -1.0% 74.62 US$842,262
2019-12-03 2019-12-02 PlS Planned sale SUVARI TRICIA BORGA

Chief Legal Officer

Officer
3,434 -33.7%
66.74
US$229,185 		3,434 -33.7% 66.74 US$229,185
2019-11-27 2019-11-26 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
11,593 -100.0%
67.19
US$778,934 		11,593 -100.0% 67.19 US$778,934
2019-11-27 2019-11-25 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
656 -100.0%
60.00
US$39,360 		656 -100.0% 60.00 US$39,360
2019-11-27 2019-11-25 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
4,594 -100.0%
60.00
US$275,640 		4,594 -100.0% 60.00 US$275,640
2019-11-27 2019-11-25 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
298 -100.0%
60.00
US$17,880 		298 -100.0% 60.00 US$17,880
2019-11-27 2019-11-25 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
447 -100.0%
60.00
US$26,820 		447 -100.0% 60.00 US$26,820
2019-11-27 2019-11-25 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
3,515 -100.0%
60.00
US$210,900 		3,515 -100.0% 60.00 US$210,900
2019-11-27 2019-11-25 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
1,108 -100.0%
60.00
US$66,480 		1,108 -100.0% 60.00 US$66,480
2019-11-27 2019-11-25 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
312 -100.0%
60.00
US$18,720 		312 -100.0% 60.00 US$18,720
2019-11-20 2019-11-19 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
6,562 -100.0%
55.00
US$360,910 		6,562 -100.0% 55.00 US$360,910
2019-11-20 2019-11-18 PlS Planned sale
Lehrer-Graiwer Joshua

Chief Medical Officer
656 -100.0%
50.63
US$33,213 		656 -100.0% 50.63 US$33,213
2019-11-18 2019-11-15 PlS Planned sale Lehrer-Graiwer Joshua

Chief Medical Officer

Officer
9,948 -100.0%
50.00
US$497,447 		9,948 -100.0% 50.00 US$497,447
2019-11-18 2019-11-14 PlS Planned sale Lehrer-Graiwer Joshua

Chief Medical Officer

Officer
329 -100.0%
50.01
US$16,455 		329 -100.0% 50.01 US$16,455
2019-11-05 2019-11-01 PlS Planned sale
SUVARI TRICIA BORGA

Chief Legal Officer
2,200 -17.8%
48.33
US$106,334 		2,200 -17.8% 48.33 US$106,334
2019-11-05 2019-11-01 PlS Planned sale
SUVARI TRICIA BORGA

Chief Legal Officer
1,127 -8.3%
48.68
US$54,857 		1,127 -8.3% 48.68 US$54,857
2019-10-10 2019-10-08 S Sale
1.4
PATRICK DEVAL L
5,357 -100.0%
45.05
US$241,333 		5,357 -100.0% 45.05 US$241,333
Explore more

More insider trading research around Global Blood Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America